Inventor

Engin Ozkaynak

Inventor

Milford, MA, US

Overview

47→

Patents

1991–2009

Patent span

Human necessities

Primary field (CPC A)

Patents· 47 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides17%

A61KPreparations for medical, dental or toiletry purposes17%

A61LMethods or apparatus for sterilising materials or objects in general16%

A61FFilters implantable into blood vessels15%

A61CDentistry8%

G01NInvestigating or analysing materials by determining their chemical or physical properties7%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%

A01NPreservation of bodies of humans or animals or plants or parts thereof3%

C04BLime, magnesia2%

PatentTitleYear

7,557,078'Morphogen-induced nerve regeneration and repair'2009 7,429,484'Nucleic acid molecules encoding osteogenic proteins'2008 7,268,208'Morphogen solubilizing peptides'2007 7,176,284'Osteogenic proteins'2007 7,078,221'Nucleic acid molecules encoding osteogenic proteins'2006 7,060,680'Morphogen treatments for limiting proliferation of epithelial cells'2006 7,056,882'Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases'2006 6,949,505'Morphogen-induced dendritic growth'2005 6,919,308'Osteogenic devices'2005 6,586,388'Method of using recombinant osteogenic protein to repair bone or cartilage defects'2003 6,551,995'Osteogenic devices'2003 6,534,277'Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins'2003 6,495,513'Morphogen-enhanced survival and repair of neural cells'2002 6,399,569'Morphogen treatments for limiting proliferation of epithelial cells'2002 6,395,883'Soluble morphogenic protein complex compositions of matter'2002 6,333,312'Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases'2001 6,297,213'Osteogenic devices'2001 6,261,835'Nucleotide sequences encoding osteogenic proteins'2001 6,153,583'OP-3 induced morphogenesis'2000 6,071,708'Morphogenic protein compositions of matter'2000 6,071,695'Methods and products for identification of modulators of osteogenic protein-1 gene expression'2000 5,994,131'Morphogenic protein screening method'1999 5,958,441'Devices comprising chondrogenic protein and methods of inducing endochondral bone formation therewith'1999 5,863,758'Nucleic acids encoding osteogenic proteins'1999 5,854,071'OP-3- induced morphongenesis'1998 5,834,179'Morphogenic protein compositions of matter'1998 5,814,604'Methods for inducing endochondral bone formation comprising administering CBMP-2A, CBMP-2B, and/or virants thereof'1998 5,750,651'Cartilage and bone-inducing proteins'1998 5,741,641'Morphogenic protein screening method'1998 5,739,107'Morphogen treatment of gastrointestinal ulcers'1998 5,714,589'Method of selectively extracting osteogenic protein'1998 5,707,810'Method of diagnosing renal tissue damage or disease'1998 5,674,844'Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases'1997 5,670,336'Method for recombinant production of osteogenic protein'1997 5,652,118'Nucleic acid encoding a novel morphogenic protein, OP-3'1997 5,652,337'OP-3-induced morphogenesis'1997 5,650,276'Morphogenic protein screening method'1997 5,610,021'Compositions and methods for identification and use of soluble complex forms of osteogenic proteins'1997 5,468,845'Antibodies to osteogenic proteins'1995 5,354,557'Osteogenic devices'1994 5,344,654'Prosthetic devices having enhanced osteogenic properties'1994 5,324,819'Osteogenic proteins'1994 5,266,683'Osteogenic proteins'1993 5,258,494'Osteogenic proteins'1993 5,250,302'Osteogenic devices'1993 5,182,365'Osteogenic proteins'1993 5,011,691'Osteogenic devices'1991

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1991–2009Patents assigned to STRYKER CORP (23)· patent assignee history

1991–2009Based in Milford, MA, US· patent location history

1997–2000Patents assigned to CREATIVE BIOMOLECULES INC (12)· patent assignee history

2000–2006Patents assigned to STRYKER BIOTECH (2)· patent assignee history

2001–2006Patents assigned to CURIS INC (6)· patent assignee history

2003Patents assigned to MILLENNIUM PHARM INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
STRYKER CORP	23	1991–2009
CREATIVE BIOMOLECULES INC	12	1997–2000
CURIS INC	6	2001–2006
STRYKER BIOTECH	2	2000–2006
MILLENNIUM PHARM INC	1	2003

Locations

Location	Patents	Span
Milford, Massachusetts, US	47	1991–2009